JNJ-73841937, PEMETREXED , JNJ-61186372, CARBOPLATIN
61186372NSC2002
Phase 2 small_molecule active
Quick answer
JNJ-73841937, PEMETREXED , JNJ-61186372, CARBOPLATIN for Advanced or Metastatic Solid Tumors including EGFR-mutated Non-Small Cell Lung Cancer. is a Phase 2 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Advanced or Metastatic Solid Tumors including EGFR-mutated Non-Small Cell Lung Cancer.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active